# BioRelix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biorelix

- Industry: Biotechnology
- Headquarters: New Haven, US
- Website: www.biorelix.com
- Total disclosed funding: $29M
- Latest round: Series A (Sep 2, 2011)
- Investors on record: 6

## About

BioRelix, Inc., is based in New Haven, US and is a biopharmaceutical company, engages in the discovery and development of anti biotic drug candidates for the treatment of infectious diseases in the United States.

## Funding rounds

- Series A, Sep 2, 2011, $3.6M — Novartis Venture Fund
- Series A, Jun 4, 2007, $26M — CHL Medical Partners, Novartis Venture Fund, Alexandria Venture Investments, Aisling Capital, New Leaf Venture Partners, Elm Street Ventures

## Investors

- CHL Medical Partners (https://capitalatlas.ai/funds/chl-medical-partners) — Series A
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series A
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- Aisling Capital (https://capitalatlas.ai/funds/aisling-capital) — Series A
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series A
- Elm Street Ventures (https://capitalatlas.ai/funds/elm-street-ventures) — Series A